(Date:7/23/2008)...in harmless moles, may be key to diagnosis , ...lanoma produces high levels of a protein called IM..., University of Rochester Medical Center researche...ctors a new way to distinguish melanoma -- the mos...es that look like melanoma. , The study was pub...
(Date:7/23/2008)...wire-USNewswire/ -- The American Heart,Association...Lewis,Achievement Award, the association,s highest...rd was established in 2000, to recognize and honor...dical journalists who have documented,the consider...ase and,stroke. This career achievement award was ...
(Date:7/23/2008)...3 /PRNewswire-USNewswire/ -- The Alameda County,Pl...y 24-26 at the Oakland,Marriott to address the soc...n individuals from low-income and communities of c... and counties will attend. Place Matters,is a nati...and Economic,Studies, Health Policy Institute and ...
(Date:7/23/2008)... Dangerous for Morbidly Obese Women? ,As the o...re consulting plastic surgeons for breast reductio...d been thought to have higher complication rates. ... as safe to perform large-volume breast reductions...tudy title: Breast Reduction: Safe in the Morbidly...
Breaking Medicine News(10 mins):Health News:Protein Gives Doctors New Tool to Detect Melanoma 2Health News:Alameda County Hosts National Initiative to Reduce Health Disparities 2... come up with a bill seeking direct control over a... centres in the state, State Health Minister Digam...roduce a special bill in the next assembly session...perating in the state. This is to check activities...
...that folic acid supplements can help to prevent ca...//. Published in the July 15, 2006 issue of CANC...oom), a peer-reviewed journal of the American Canc...1 of 43 patients with the precancerous laryngeal l...
...rogrammer flew in to Boston from India, on April 2...ervices company headquartered //in the 18th floor ...ze that a potential measles outbreak loomed before...toms of measles such as rash, fever, cough began t...
...t a new report looked at new prescription- only m...d 2006 //. In the last six years, 78 new prescri...alian PBS, which was the equivalent of Pharmac. O...stered in New Zealand, of which only 20 are funde...
Other Medicine News:Health News:Folic Acid Supplements to Prevent Cancer 2Health News:Global Threat of Measles Outbreak 2(Date:7/22/2008)...APOLIS, July 22 /- Nonin Medical, a l...ions for more than 20 years, has entered,the clini... to measure,regional oxygen saturation. Today,s mo...ontinuous monitoring of the regional blood oxygena...sting data and outcomes from an ongoing clinical s...
(Date:7/22/2008)...Demonstrates Feasibility and Efficacy of Treating ...er Cancer, SAN FRANCISCO, and YONGIN-SI, South Ko...rancisco, CA and Ottawa, Ontario), and its South,K...hat novel findings from,a Phase I clinical trial o...ted that the product was well-tolerated and result...
(Date:7/22/2008)...offrey Allan Will Stress the Importance to Patient...s Approval Pathway, RICHMOND, Va., July 22 /PRNew...a developer of follow-on biologics and biopharmace...., CEO of Insmed, will present at a,Congressional ...,significant need for establishing an approval pat...
(Date:7/22/2008)...loped and Validated by Columbia University Medical...ietary MicroRNA Technology, The Test Differentia... Cancer (NSCLC), Classifying Squamous-Cell Carcin...ent and Specificity of 90 Percent,This is the Firs...nsitivity as Biomarkers for Accurate Diag...
Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 2First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 3First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 4First Cancer Diagnostic Test Based on Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval 5First Lady Honors Women at International Womens Day Event 13817 1First Lady Honors Women at International Womens Day Event 13817 2Advanced Life Sciences Receives Nasdaq Notification 3796 1Advanced Life Sciences Receives Nasdaq Notification 3796 2Advanced Life Sciences Receives Nasdaq Notification 3796 3Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 1Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 2Researchers Design Promising Cancer Drug 13810 1Researchers Design Promising Cancer Drug 13810 2... 05, 2007 /PRNewswire-FirstCall/ --,Nuvelo, Inc. t...linical study of novel monoclonal antibodies again...trate that NTB-A is a,potential new target for imm...ia and lymphomas. The study, entitled "The lymphoi...antibody target for,leukemia and lymphoma therapeu...
...SS WIRE)--Jun 5, 2007 - NovaDel Pharma,Inc. (AMEX:...ng,oral spray formulations for a broad range of ma...inical studies comparing zolpidem,oral spray with ...netic (PK), pharmacodynamic (PD) and safety object...mbien(R), a leading,drug for the treatment of inso...
Other Medicine Technology:Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 2Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 3Nuvelo Announces Publication of Preclinical Study Results,Demonstrating the Potential of NTB-A as a New Target for Leukemia,and Lymphomas 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 2NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 3NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 4NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 5NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 6NovaDel Announces Positive Data from Two Studies Comparing Zolpidem,Oral Spray to Ambien Tablets 7Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua
Tube for Left Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Graduat
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea.
For MicroLaryngeal Tracheal Surgery
Medicine Products: